Easton Pharmaceuticals Inc. announced update to its signed agreement with Bayer Consumer Care. As previously announced, Easton Pharmaceuticals, through its partner BMV Medica SA de CV, entered into an agreement with BAYER and BAYER Consumer Care of Switzerland, for a sub-distribution agreement for Easton /BMVs licensed product known as VS-Sense for the territory of Mexico. After many inquiries from shareholders requesting further confirmation and updates, Easton can disclose and confirm its agreement has closed and that an initial cash payment from BAYER was received as per terms of its executed agreement. An additional payment is due upon product launch, as well as royalties paid on each product sold for a period of five years as per terms of its executed agreement. The launch date for VS-Sense, which will most likely be marketed and sold under a new BAYER brand name is in the planning stages and is BAYERs sole responsibility and decision to make. Easton will provide additional detailed updates to its shareholders once Easton is officially notified by BAYER.